retatrutide triple agonist obesity Eli Lilly's shows promising weight loss results in phase 3 trial Retatrutide Severe Obesity Trial Shows

Project administration: Hilda E

How to make it: Toast one slice of sprouted grain bread Mash of a ripe avocado on top Sprinkle with salt, pepper, and (if you like) a pinch of crushed red pepper or lemon juice Serve with a side of cucumber slices or cherry tomatoes for added fiber and hydration

Fertility Issues in Polycystic Ovarian Disease: A Systematic Approach

MAXIMUM RESULTS Starting at $250/month Targets BOTH GLP-1 and GIP receptors Average 2022% body weight loss (SURMOUNT trial data) Once-weekly subcutaneous injection Stronger insulin sensitivity benefit Often greater appetite suppression Compounded by licensed 503A pharmacy Patients seeking maximum weight loss results, those with insulin resistance or pre-diabetes, or anyone who didn't respond optimally to semaglutide alone

12 mg = 28.7% weight loss at 68 weeks

Given their metabolic and signaling effects, SGLT2 inhibitors may have synergy with existing cancer therapies, such as chemotherapy, immunotherapy, or targeted therapies